Sign In
Buy AACAY
$6.03
-0.160 (-2.58%)
At Close: Jun 22, 2026
AAC&U Releases New Report on Advancing Public Trust in Higher Education
08:00am, Tuesday, 16'th Jun 2026
"The Trust Agenda" outlines strategies for strengthening relationships between colleges and universities and the communities they serve. "The Trust Agenda" outlines strategies for strengthening relati
AAC Clyde Space AB (publ) (ACCMF) Q1 2026 Earnings Call Transcript
09:10am, Wednesday, 13'th May 2026
AAC Clyde Space AB (publ) (ACCMF) Q1 2026 Earnings Call Transcript
AAC Clyde Space AB (publ) (ACCMF) Q4 2026 Guidance Call Transcript
08:31am, Tuesday, 28'th Apr 2026
AAC Clyde Space AB (publ) (ACCMF) Q4 2026 Guidance Call Transcript
Developed with a licensed speech-language pathologist and the Autism Society of America, this freecommunication tool helps fill a gap in Augmentative and Alternative Communication (AAC) vocabulary,giv
AAC Technologies Holdings Inc. (AACAY) Q4 2025 Earnings Call Transcript
07:15pm, Friday, 27'th Mar 2026
AAC Technologies Holdings Inc. (AACAY) Q4 2025 Earnings Call Transcript
AAC Clyde Space AB (publ) (ACCMF) Q4 2025 Earnings Call Transcript
07:45am, Thursday, 19'th Feb 2026
AAC Clyde Space AB (publ) (ACCMF) Q4 2025 Earnings Call Transcript
Are Investors Undervaluing AAC Technologies (AACAY) Right Now?
10:41am, Thursday, 22'nd Jan 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas
07:30am, Monday, 12'th Jan 2026
LEXINGTON, Mass.--(BUSINESS WIRE)---- $AGEN #BAL--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that France's National Agency for Medicines and Health Products Sa
Is AAC Technologies (AACAY) Stock Undervalued Right Now?
01:26pm, Tuesday, 06'th Jan 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
AAC Technologies (OTCMKTS:AACAY) Share Price Crosses Below 50 Day Moving Average – Here’s Why
02:05am, Friday, 26'th Dec 2025
AAC Technologies Holdings Inc. (OTCMKTS:AACAY - Get Free Report) crossed below its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $4.94 and traded as low as
GenSight Biologics Announces the Granting of Compassionate Use Authorization (CUA/AAC) for GS010/LUMEVOQ® in France
01:00am, Monday, 22'nd Dec 2025
PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene thera
AAC Clyde Space AB (publ) (ACCMF) Discusses Strategic Investment from Bonnier Capital to Support Growth and INFLECION Programme Transcript
Accelerating the Global Commercialization of AR Waveguide Technology with AAC Technologies
08:44am, Tuesday, 18'th Nov 2025
Espoo, Finland, Nov. 18, 2025 (GLOBE NEWSWIRE) -- AAC Technologies Pte. Ltd. (the “AAC”), a world-leading smart device solution provider and a company incorporated in Singapore and a fully-owned
Should Value Investors Buy AAC Technologies (AACAY) Stock?
10:41am, Friday, 17'th Oct 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Are Investors Undervaluing AAC Technologies (AACAY) Right Now?
10:41am, Wednesday, 01'st Oct 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
